Reuters - Gleevec, the pill that transformed cancer treatments by offering an easy way to target a difficult type of leukemia, may cause serious heart damage, researchers cautioned on Sunday.

HealthDay - THURSDAY, June 29 (HealthDay News) -- U.S. regulators gave accelerated approval Wednesday to a new targeted therapy to treat people with chronic myeloid leukemia (CML).

The U.S. Food and Drug Administration (FDA) has approved a new drug to treat chronic myeloid leukemia (CML). The FDA granted accelerated approval Wednesday to Bristol-Myers Squibb Co.'s drug, Sprycel (dasatinib), as an oral inhibitor of multiple tyrosine kinases, for the treatment of adults in...

HealthDay - THURSDAY, June 29 (HealthDay News) -- U.S. regulators gave accelerated approval Wednesday to a new targeted therapy to treat people with chronic myeloid leukemia (CML).

AP - A Bristol-Myers Squibb Co. drug received accelerated federal approval Wednesday to treat some leukemias where other drugs have failed.

Reuters - A new Bristol-Myers Squibb Co. pill won U.S. approval for fighting two types of leukemia in patients running out of treatment options, the company said on Wednesday.

Reuters - The risk of leukemia in childhood appears to be increased when fathers smoke, even if the smoking occurs before conception, and with exposure to smoking after birth, researchers report in the American Journal of Epidemiology.

HealthDay - TUESDAY, June 27 (HealthDay News) -- New information about the role of bone marrow stem cells could lead to important advances in treating diseases like leukemia, lupus and rheumatoid arthritis, scientists say.

HealthDay - TUESDAY, June 27 (HealthDay News) -- New information about the role of bone marrow stem cells could lead to important advances in treating diseases like leukemia, lupus and rheumatoid arthritis, scientists say.

Reuters - Scientists in Hong Kong believe they have uncovered the trigger for leukemia, a cancer of the blood that afflicts millions worldwide.

Reuters - Two new drugs may help treat some adult cases of leukemia that fail to respond to Novartis AG's Gleevec, two studies showed on Wednesday.

Reuters - Two new drugs may help treat some adult cases of leukemia that fail to respond to Novartis AG's Gleevec, two studies showed on Wednesday.

Reuters - German drugmaker Schering AG and U.S. biotech firm Genzyme Corp have seen good preliminary results in a study of the drug MabCampath to treat leukemia, Schering said in a statement.

AP - A Bristol-Myers Squibb Co. drug should receive accelerated federal approval to treat some leukemias where other drugs have failed, a panel of outside experts recommended Friday.

Reuters - Children living near nuclear plants in France do not have an increased risk of leukemia, a new study confirms.

A sperm donor transmits a rare and serious genetic disorder to five children. The children, born to four couples, all have severe congenital neutropenia, which puts them at higher risk for infections and leukemia. They are currently healthy, but they...

A young man who took part in the clinical trial of a drug intended to treat autoimmune diseases and leukemia will lose parts of his fingers and toes. Ryan Wilson, 20, was among six healthy volunteers who suffered convulsions and organ...

Reuters - A type of stem cell therapy called hematopoietic cell transplantation (HCT) often leads to a reduction in bone formation in children, according to Minneapolis-based researchers. HCT is used to treat cancers of the blood such as leukemia.

AP - They were chosen because they were fit and healthy, but minutes after being injected with a test drug designed to combat leukemia and other diseases, the men went into convulsions as their internal organs began to fail.

AP - The first test in humans of a new drug to treat leukemia and autoimmune diseases has left six men severely ill, sparking fresh questions over the safety of such clinical trials.